(3-BROMO-5-FORMYLPHENYL)BORONIC ACID PINACOL ESTER, 95.0%, 1g

3-(Cyanomethyl)benzonitrile, 95.0%, 5g

Cyanobis(propan-2-yl)amine, 95%, 1g

2-(1-Benzothiophen-3-yl)acetonitrile, 95+%, 10g

Combretastatin A4, 98.0%, 250mg

TERT-BUTYL N-[(4,4-DIMETHYLPYRROLIDIN-3-YL)METHYL]CARBAMATE, 95.0%, 1g

2,1,3-Benzoxadiazole, 97.0%, 1g

7-Bromo-4-methylbenzofuran, 95.0%, 5g

1,2-Di-p-tolylethane-1,2-diamine, 98%, 25g

METHANESULFONIC ACID 1-PROPIONYL-PIPERIDIN-4-YLMETHYL ESTER, 95.0%, 500mg

Hybridisation vial Non-coated, Height, 100 mm, 35 mm, 1 Piece

Benzo[1,3]dioxol-5-yl-(4-hydroxy-piperidin-1-yl)-methanone, 95.0%, 250mg

4-Fluoro-2-formylpyridine, 95.0%, 250mg